Skip to main content
. 2002 Nov;46(11):3381–3385. doi: 10.1128/AAC.46.11.3381-3385.2002

TABLE 2.

In vivo mutations conferring rifampin resistance on S. aureus isolates of various PFGE genotypes

Origin PFGE genotypea Rifampin MIC (μg/ml) Amino acid change(s)
Germany A 2 481His→Asn
Germany B 2 481His→Asn
Germany N 2 481His→Asn
Germany P 2 481His→Asn
United States K 2 481His→Asn
Germany D 2 481His→Asn
Germany O 256 481His→Asn, 529Ser→Leu
France C 256 481His→Asn, 529Ser→Leu
France B 256 481His→Asn, 529Ser→Leu
Slovenia I 256 481His→Asn, 529Ser→Leu
Poland J 256 481His→Asn, 529Ser→Leu
Italy S 256 481His→Asn, 529Ser→Leu
Italy Q 256 481His→Asn, 529Ser→Leu
Germany B 512 481His→Asn, 465Gln→Arg, 529Ser→Leu
Germany E >512 481His→Asn, 473Ala→Thr, 477Ala→Thr
Germany L 512 481His→Asn, 466Leu→Ser
Germany M 512 481His→Asn, 466Leu→Ser
Germany H 512 481His→Asn, 466Leu→Ser
Germany G 512 481His→Asn, 466Leu→Ser
Italy S 512 481His→Asn, 527Ile→Met
Italy R 512 481His→Asn, 527Ile→Met
Germany D 512 468Gln→Lys
Germany F 512 468Gln→Lys
a

S. aureus strains exhibiting the same macrorestriction pattern among PFGE analyses were assigned to the same PFGE genotype. The genotypes were arbitrarily denoted by capital letters.